Loading stock data…
MiniMed Group, Inc. (MMED)
$23.32+0.03 (+0.15%)
Market ClosedLast close Sep 8
MiniMed Group, Inc.
Historical Price
Price (Candle)
Synthesizing Whystock Narrative...
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $837.00M↑ | $790.00M | — | $724.00M↑ | $687.00M |
| Gross Profit | $480.00M↑ | $362.00M | — | $402.00M↑ | $395.00M |
| Operating Income | -$87.00M↑ | -$93.00M | — | -$38.00M↓ | $22.00M |
| Net Income | -$185.00M↓ | -$119.00M | — | -$209.00M↓ | -$10.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$6.56B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-14.21%
Volume
Today's trading volume
1.05M
Recent News
MiniMed (MMED) Q1 2027 Earnings Call Transcript
Flex pump launch drives 15.8% revenue growth and guidance raise.
Why MiniMed Stock Was Soaring This Week
It easily topped analyst revenue estimates in its opening quarter of fiscal 2027.
MiniMed Group (MMED) Starts Fiscal 2027 Strong As Product And Regulatory Progress Builds
MiniMed Group (NasdaqGS: MMED) reported a strong start to fiscal 2027, with management pointing to accelerated U.S. growth and broader international uptake. The company highlighted progress on next generation products, including trial completions that support its device pipeline. Regulatory updates included advancements with both FDA and CE Mark processes, alongside an improved revenue outlook for the fiscal year. For investors tracking how medical technology and software are reshaping...
Company News for Sep 2, 2026
Companies In The News Are: MDT, MMED, NIO, AAPL.
MiniMed (MMED) Soars on Revenue Growth, Price Target Hike; Hedge Fund Conviction Weakens
MiniMed Group (NASDAQ:MMED) saw its share price increase by 10.66 percent on Tuesday to finish at $22.42 apiece after reporting strong revenues and earning a price target upgrade from an investment firm. In an earnings call on the same day, the company said that it was able to grow its revenues in the first quarter […]